Exocrine Pancreatic Insufficiency

The diagnosis of EPI will be made through the combination of two diagnostic tests.
The labeled triolein breath test will use criteria established by the manufacturer of the product (Pancreo-Kit®) Isomed pharma.
The fecal elastase test will be performed at our own center (Bioserv Diagnostics (BS-86-01 Elastase Pancreatic ELISA) distributed by Palex Medical.) In those cases where both results are negative, it will be considered that there is no EPI. In cases where both results are positive, the diagnosis of EPI will be performed. If the results are discordant, a Sobel test or feces quantification test will be performed.

Labeled triolein urea breath test

Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis

The diagnosis of EPI will be made through the combination of two diagnostic tests.
The labeled triolein breath test will use criteria established by the manufacturer of the product (Pancreo-Kit®) Isomed pharma.
Reference value: Normal: > 29%; Pathological: < 29% of the fat administered
The fecal elastase test (Bioserv Diagnostics (BS-86-01 Elastase Pancreatic ELISA) distributed by Palex Medical.)
A normal result will be considered: 200 to > 500 μg / g
Slight exocrine pancreatic insufficiency- Moderate: 100 - 200 μg / g
Severe exocrine pancreatic insufficiency: <100 μg / g
In those cases where both results are negative, it will be considered that there is no EPI. In cases where both results are positive, the diagnosis of EPI will be performed. If the results are discordant, a Sobel test or feces quantification test will be performed.
Coefficient of fat absorption; Pathological if elimination > 7g of fat / day with a diet of 100g fat / day.

chymotrypsin/hemorrhage

Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis

Baz done ki pi konplè remèd fèy medsin te apiye nan syans